Pilot randomised controlled trial on the feasibility and intervention satisfaction with an educational group programme for adults with attention deficit hyperactivity disorder and their caregivers

被引:0
|
作者
Skliarova, Tatiana [1 ]
Grawe, Rolf W. [1 ,2 ]
Vaag, Jonas [3 ]
Mandahl, Arthur [4 ]
Kolltveit, Inger [5 ]
Lovas, Ina [5 ]
Torgersen, Terje [1 ,5 ]
Lara-Cabrera, Mariela L. [1 ,5 ]
机构
[1] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Mental Hlth, Trondheim, Norway
[2] St Olavs Univ Hosp, Dept Mental Hlth Care, Trondheim, Norway
[3] Inland Univ Appl Sci, Dept Psychol, Lillehammer, Norway
[4] Varres Reg User Led Ctr Midnorway, Trondheim, Norway
[5] Trondheim Reg & Univ Hosp, St Olavs Hosp, Nidelv Community Mental Hlth Ctr, Dept Mental Healthcare, Trondheim, Norway
关键词
Acceptability; Adult attention deficit hyperactivity disorder (ADHD); Caregivers; Patient satisfaction; Patient education; Peer-cofacilitated education; Person-centred care; Psychoeducation; Quality of life (QoL); Randomised controlled trial (RCT); Self-efficacy; SIGNIFICANT OTHERS PEGASUS; MENTAL-HEALTH TREATMENT; SELF-MANAGEMENT; PSYCHOEDUCATIONAL GROUPS; PATIENT EDUCATION; USER INVOLVEMENT; ADHD; CARE; PROFESSIONALS; IMPAIRMENT;
D O I
10.1186/s12888-025-06570-4
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundThis pilot randomised controlled trial (RCT) study presents a patient-centred educational group programme collaboratively developed with user representatives and caregivers from two organisations and health personnel from a community mental health centre (CMHC). The objectives were to investigate the feasibility of the psychoeducational programme and the satisfaction of outpatients and caregivers with programme participation. This RCT explored the potential benefits of this innovative psychoeducational programme for adults recently diagnosed with attention deficit hyperactivity disorder (ADHD).MethodsThis pilot study employed a two-arm RCT design and recruited 60 outpatients from a Norwegian CMHC. The CMHC clinicians offered the intervention group (IG) participants a two-session, patient-centred, peer-cofacilitated programme along with the standard treatment. The control group (CG) received the standard treatment and a 1-h individual informational session during the same period. The recruitment, attendance, and dropout rate indicators were assessed for feasibility. Acceptability was assessed via the Client Satisfaction Questionnaire four-item scale (CSQ-4) and a three-item scale evaluating patient satisfaction with the information provided about ADHD. In addition, four patient-reported outcome measures (PROMs) were applied: one scale to assess self-efficacy, two to assess ADHD symptoms, and one for quality of life. The statistical analysis applied intention-to-treat (ITT) and per-protocol (PP) analyses.ResultsIn total, 56 outpatients were divided into the IG (n = 30) or CG (n = 26), and the recruitment rate was 93.3%, with a dropout rate of 16%. The attendance rate was 92%, and the retention rates for the IG and CG were 56.6% and 76.9%, respectively. Concerning intervention satisfaction, the ITT analysis conducted using a linear mixed model revealed statistical improvements in satisfaction, with the scale measuring satisfaction with the information and the CSQ-4 scale. In addition, caregivers expressed high satisfaction with the programme, as measured by the CSQ-4 scale. Regarding PROMs, the ITT and PP analyses yielded mixed findings.ConclusionPreliminary evidence indicates that a two-session, patient-centred, peer-cofacilitated psychoeducational programme is feasible and well-received, with high ratings for satisfaction from outpatients and caregivers.Cliniclatrials.gov IdentifierNCT03547843, 27/01/2022.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Cognitive Functional Remote Group intervention for adults with attention deficit hyperactivity disorder: A feasibility study
    Galili-Simhon, Shoval
    Maeir, Adina
    BRITISH JOURNAL OF OCCUPATIONAL THERAPY, 2023, 86 (10) : 686 - 696
  • [2] The Effects of Different Exercise Approaches on Attention Deficit Hyperactivity Disorder in Adults: A Randomised Controlled Trial
    Dinu, Larisa M.
    Singh, Samriddhi N.
    Baker, Neo S.
    Georgescu, Alexandra L.
    Singer, Bryan F.
    Overton, Paul G.
    Dommett, Eleanor J.
    BEHAVIORAL SCIENCES, 2023, 13 (02)
  • [3] Oxcarbazepine in adults with attention deficit hyperactivity disorder: a clinical pilot trial
    Kis, B
    Specka, M
    Gastpar, M
    Davids, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S595 - S595
  • [4] A pilot clinical trial of oxcarbazepine in adults with attention deficit hyperactivity disorder
    Davids, E
    Specka, M
    Gastpar, M
    PHARMACOPSYCHIATRY, 2005, 38 (05) : 235 - 236
  • [5] A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults
    Wilens, TE
    Spencer, TJ
    Biederman, J
    Girard, K
    Doyle, R
    Prince, J
    Polisner, D
    Solhkhah, R
    Comeau, S
    Monuteaux, MC
    Parekh, A
    AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (02): : 282 - 288
  • [6] Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial
    Cooper, Ruth E.
    Williams, Emma
    Seegobin, Seth
    Tye, Charlotte
    Kuntsi, Jonna
    Asherson, Philip
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 (08) : 795 - 808
  • [7] Cannabinoids in attention-deficit/hyperactivity disorder: a randomised-controlled trial
    Cooper, R. E.
    Williams, E.
    Seegobin, S.
    Tye, C.
    Kuntsi, J.
    Asherson, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S130 - S131
  • [8] A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder
    Davids, Eugen
    Kis, Bemhard
    Specka, Michael
    Gastpar, Markus
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (06): : 1033 - 1038
  • [9] A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder
    Stevenson, CS
    Whitmont, S
    Bornholt, L
    Livesey, D
    Stevenson, RJ
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2002, 36 (05): : 610 - 616
  • [10] A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder
    Paterson, R
    Douglas, C
    Hallmayer, J
    Hagan, M
    Krupenia, Z
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1999, 33 (04): : 494 - 502